Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)
_ga
ID used to identify users
2 years
_gali
Used by Google Analytics to determine which links on a page are being clicked
30 seconds
_ga_
ID used to identify users
2 years
_gid
ID used to identify users for 24 hours after last activity
24 hours
_gat
Used to monitor number of Google Analytics server requests when using Google Tag Manager
1 minute
_gac_
Contains information related to marketing campaigns of the user. These are shared with Google AdWords / Google Ads when the Google Ads and Google Analytics accounts are linked together.
90 days
__utma
ID used to identify users and sessions
2 years after last activity
__utmt
Used to monitor number of Google Analytics server requests
10 minutes
__utmb
Used to distinguish new sessions and visits. This cookie is set when the GA.js javascript library is loaded and there is no existing __utmb cookie. The cookie is updated every time data is sent to the Google Analytics server.
30 minutes after last activity
__utmc
Used only with old Urchin versions of Google Analytics and not with GA.js. Was used to distinguish between new sessions and visits at the end of a session.
End of session (browser)
__utmz
Contains information about the traffic source or campaign that directed user to the website. The cookie is set when the GA.js javascript is loaded and updated when data is sent to the Google Anaytics server
6 months after last activity
__utmv
Contains custom information set by the web developer via the _setCustomVar method in Google Analytics. This cookie is updated every time new data is sent to the Google Analytics server.
2 years after last activity
__utmx
Used to determine whether a user is included in an A / B or Multivariate test.
18 months
2 thoughts on “National MS Society Invests in Clinical Development of Human Antibody for Progressive forms of MS”
I was reading an article today regarding Cognitive research that Patricia Inacio PhD published. I have had MS 20yrs now and at 35 I became fully disabled with cognitive decline. I would be interested in corresponding with Patricia Inacio PhD regarding her research. I have disagreed in many ways over the years how people are tested for cognitive related issues. At age 40 it’s taken me years to teach myself how to deal with cognition issues, yet it is almost impossible for most to understand how it affects you (example: today I took over an hour to complete a detailed grocery list to see if it helped me while shopping but unfortunately I still spent over 3 hours shopping and that’s just for groceries).
I was that multiple sclerosis Wasn’t so different across-the-board. It makes it difficult for help to be given where it needs to be for an individual person because they focus more on the big picture issues then on things that aren’t what they deem big picture. Cognitive is a big one as an example because it’s not one of the top MS symptoms that everyone has. I don’t suffer from cognitive but I have all the physical. I’m secondary progressive And there’s no help for me. Everything that’s really done is still mostly for relapsing remitting. There is very little out there for secondary that actually works. There’s even less support financially for the disabled with MS. It is all difficult. I’m sorry I wish I could help you.